Thursday, 8 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Kilitch Drugs(I) Ltd

NSE: KILITCH · BSE: 524500 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹256.25
Market cap: ₹895.9 Cr
Revenue (annual): ₹235.5 Cr
Net profit (annual): ₹30.17 Cr
P/E (TTM): 29.8×Sector 47.3×
Promoter holding: 63.77%+0.00% QoQ
FII holding: 0.12%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Financial Results 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Aug 2026 20:53 IST BSE

Financial Results

Kilitch Drugs(I) Q1 FY27 Results: Net Profit ₹2 Cr, Down 13.0% YoY

Kilitch Drugs(I) Ltd reported revenue from operations of ₹44.9 Cr (+4.2% YoY) and net profit of ₹2 Cr (-13.0% YoY) for Q1 FY27.

Key figure: Net profit ₹2 Cr · -13.0% YoY

Open full results → Read the filing ↗